Showing 1371-1380 of 3232 results for "".
The HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.Emerging Therapies in the Evolving Biologic Platform for Psoriasis Treatment
https://practicaldermatology.com/topics/practice-management/emerging-therapies-in-the-evolving-biologic-platform-for-psoriasis-treatment/21377/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20513/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-42/23844/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-12/23254/New Products
https://practicaldermatology.com/columns/new-products/new-products-2/23356/Can Dupilumab Improve Keloid Scarring?
https://practicaldermatology.com/topics/skin-of-color/can-dupilumab-improve-keloid-scarring/23820/Coming Soon: New Biopsy Codes
https://practicaldermatology.com/topics/general-topics/coming-soon-new-biopsy-codes/20411/Is your practice prepared for changes to the CPT codes?Skin Cancer Is Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-emisem-cancer/21341/GLP-1RAs and the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1ras-and-the-dermatologist/48885/We are only beginning to understand the implications of GLP-1s for skin and systemic health. These medications are here to stay, and dermatology must be part of the conversation.